Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Niche Biomedical is a neurotechnology company developing next-generation implantable systems designed to restore physiological functions in patients with spinal cord injuries and other neurological disorders. The company's core technology is a high-density, wireless neurostimulation platform that enables precise modulation of neural circuits without the need for bulky leads or external power cables. Initially focused on restoring autonomic functions such as bladder, bowel, and sexual health, the platform is engineered to be scalable for a wide range of neuromodulation applications. By leveraging advanced microelectronics and neural engineering, Niche Biomedical aims to overcome the limitations of traditional wired stimulators to provide a more effective and less invasive solution for permanent neurological deficits. The company is a spin-off from research conducted at UCLA and is led by pioneers in the field of bioelectronic medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Niche Biomedical.